Logo image of ZS

ZSCALER INC (ZS) Stock Fundamental Analysis

NASDAQ:ZS - Nasdaq - US98980G1022 - Common Stock - Currency: USD

313.94  -1.38 (-0.44%)

After market: 313.6 -0.34 (-0.11%)

Fundamental Rating

4

Overall ZS gets a fundamental rating of 4 out of 10. We evaluated ZS against 282 industry peers in the Software industry. The financial health of ZS is average, but there are quite some concerns on its profitability. ZS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ZS was profitable.
In the past year ZS had a positive cash flow from operations.
In the past 5 years ZS always reported negative net income.
In the past 5 years ZS always reported a positive cash flow from operatings.
ZS Yearly Net Income VS EBIT VS OCF VS FCFZS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

ZS's Return On Assets of -0.73% is fine compared to the rest of the industry. ZS outperforms 61.35% of its industry peers.
ZS's Return On Equity of -2.15% is fine compared to the rest of the industry. ZS outperforms 63.48% of its industry peers.
Industry RankSector Rank
ROA -0.73%
ROE -2.15%
ROIC N/A
ROA(3y)-6.87%
ROA(5y)-7.7%
ROE(3y)-33.5%
ROE(5y)-34.76%
ROIC(3y)N/A
ROIC(5y)N/A
ZS Yearly ROA, ROE, ROICZS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 77.38%, ZS is doing good in the industry, outperforming 73.76% of the companies in the same industry.
In the last couple of years the Gross Margin of ZS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ZS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-0.59%
ZS Yearly Profit, Operating, Gross MarginsZS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

5

2. Health

2.1 Basic Checks

ZS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZS has been increased compared to 1 year ago.
ZS has more shares outstanding than it did 5 years ago.
ZS has a better debt/assets ratio than last year.
ZS Yearly Shares OutstandingZS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ZS Yearly Total Debt VS Total AssetsZS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

ZS has an Altman-Z score of 8.54. This indicates that ZS is financially healthy and has little risk of bankruptcy at the moment.
ZS has a better Altman-Z score (8.54) than 80.85% of its industry peers.
ZS has a debt to FCF ratio of 1.66. This is a very positive value and a sign of high solvency as it would only need 1.66 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.66, ZS is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
A Debt/Equity ratio of 0.64 indicates that ZS is somewhat dependend on debt financing.
ZS's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. ZS is outperformed by 68.09% of its industry peers.
Even though the debt/equity ratio score it not favorable for ZS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1.66
Altman-Z 8.54
ROIC/WACCN/A
WACC8.73%
ZS Yearly LT Debt VS Equity VS FCFZS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.24 indicates that ZS should not have too much problems paying its short term obligations.
The Current ratio of ZS (1.24) is worse than 61.70% of its industry peers.
A Quick Ratio of 1.24 indicates that ZS should not have too much problems paying its short term obligations.
The Quick ratio of ZS (1.24) is worse than 61.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
ZS Yearly Current Assets VS Current LiabilitesZS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

9

3. Growth

3.1 Past

ZS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.85%, which is quite good.
Measured over the past years, ZS shows a very strong growth in Earnings Per Share. The EPS has been growing by 70.72% on average per year.
Looking at the last year, ZS shows a very strong growth in Revenue. The Revenue has grown by 25.46%.
The Revenue has been growing by 48.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)10.85%
EPS 3Y81.9%
EPS 5Y70.72%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)25.46%
Revenue growth 3Y47.68%
Revenue growth 5Y48.24%
Sales Q2Q%22.57%

3.2 Future

ZS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.65% yearly.
The Revenue is expected to grow by 21.26% on average over the next years. This is a very strong growth
EPS Next Y3.04%
EPS Next 2Y8.77%
EPS Next 3Y12.87%
EPS Next 5Y17.65%
Revenue Next Year24.2%
Revenue Next 2Y22.21%
Revenue Next 3Y21.4%
Revenue Next 5Y21.26%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZS Yearly Revenue VS EstimatesZS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
ZS Yearly EPS VS EstimatesZS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15

1

4. Valuation

4.1 Price/Earnings Ratio

ZS is valuated quite expensively with a Price/Earnings ratio of 96.01.
Compared to the rest of the industry, the Price/Earnings ratio of ZS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.98, ZS is valued quite expensively.
ZS is valuated quite expensively with a Price/Forward Earnings ratio of 83.18.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, ZS is valued quite expensively.
Industry RankSector Rank
PE 96.01
Fwd PE 83.18
ZS Price Earnings VS Forward Price EarningsZS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 70.28
EV/EBITDA N/A
ZS Per share dataZS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZS does not grow enough to justify the current Price/Earnings ratio.
ZS's earnings are expected to grow with 12.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)31.55
PEG (5Y)1.36
EPS Next 2Y8.77%
EPS Next 3Y12.87%

0

5. Dividend

5.1 Amount

No dividends for ZS!.
Industry RankSector Rank
Dividend Yield N/A

ZSCALER INC

NASDAQ:ZS (6/30/2025, 4:13:46 PM)

After market: 313.6 -0.34 (-0.11%)

313.94

-1.38 (-0.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)09-01 2025-09-01/amc
Inst Owners58.21%
Inst Owner Change11.24%
Ins Owners36.7%
Ins Owner Change1.56%
Market Cap48.57B
Analysts80.36
Price Target316.8 (0.91%)
Short Float %8.61%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.9%
Min EPS beat(2)8.39%
Max EPS beat(2)9.41%
EPS beat(4)4
Avg EPS beat(4)14.72%
Min EPS beat(4)8.39%
Max EPS beat(4)22.98%
EPS beat(8)8
Avg EPS beat(8)22.02%
EPS beat(12)12
Avg EPS beat(12)19.58%
EPS beat(16)16
Avg EPS beat(16)23.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.12%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-1.03%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)1.35%
Revenue beat(8)6
Avg Revenue beat(8)0.62%
Revenue beat(12)9
Avg Revenue beat(12)0.61%
Revenue beat(16)13
Avg Revenue beat(16)1.4%
PT rev (1m)30.08%
PT rev (3m)35.26%
EPS NQ rev (1m)3.22%
EPS NQ rev (3m)3.13%
EPS NY rev (1m)4.02%
EPS NY rev (3m)6.5%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 96.01
Fwd PE 83.18
P/S 19.07
P/FCF 70.28
P/OCF 52.49
P/B 26.91
P/tB 36.36
EV/EBITDA N/A
EPS(TTM)3.27
EY1.04%
EPS(NY)3.77
Fwd EY1.2%
FCF(TTM)4.47
FCFY1.42%
OCF(TTM)5.98
OCFY1.91%
SpS16.46
BVpS11.67
TBVpS8.63
PEG (NY)31.55
PEG (5Y)1.36
Profitability
Industry RankSector Rank
ROA -0.73%
ROE -2.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.38%
FCFM 27.14%
ROA(3y)-6.87%
ROA(5y)-7.7%
ROE(3y)-33.5%
ROE(5y)-34.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-0.59%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1.66
Debt/EBITDA N/A
Cap/Depr 210.64%
Cap/Sales 9.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z 8.54
F-Score4
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)205.41%
Cap/Depr(5y)204.29%
Cap/Sales(3y)8.42%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.85%
EPS 3Y81.9%
EPS 5Y70.72%
EPS Q2Q%-4.55%
EPS Next Y3.04%
EPS Next 2Y8.77%
EPS Next 3Y12.87%
EPS Next 5Y17.65%
Revenue 1Y (TTM)25.46%
Revenue growth 3Y47.68%
Revenue growth 5Y48.24%
Sales Q2Q%22.57%
Revenue Next Year24.2%
Revenue Next 2Y22.21%
Revenue Next 3Y21.4%
Revenue Next 5Y21.26%
EBIT growth 1Y10.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.45%
EBIT Next 3Y37.05%
EBIT Next 5YN/A
FCF growth 1Y125.05%
FCF growth 3Y59.67%
FCF growth 5Y83.91%
OCF growth 1Y115.44%
OCF growth 3Y56.87%
OCF growth 5Y68.16%